An abundance of evidence supports a role for aberrant cellular responses to developmentally important signaling molecules in the biogenesis of cancer. The therapeutic value of agents being developed to target these pathways, such as those controlled by the Hedgehog and Wnt signaling molecules are likely to be diminished in children or child-bearing women due to the dependency of normal developmental processes on these pathways. The long-term goal of our research is to understand the mechanisms that would enable us to target such pathways in disease with minimal consequences to normal developmental processes. In this proposal, we will uncover the interactions of two novel inhibitors of the Hh and Wnt/2-catenin signal transduction pathways with developing tissues in vertebrates using zebrafish as a model organism. In identifying the developmental processes that are influenced by transient exposure to these small molecules, we will establish the necessary knowledgebase to successfully predict and minimize unwanted effects from therapeutic targeting of these developmental and oftentimes cancerous pathways.

Public Health Relevance

In the last decade, significant advances have been made toward achieving chemical control of key developmental signal transduction pathways that are frequently corrupted in cancer. Given the promise of these therapeutic strategies and the perils that they pose for developing individuals, we propose to systematically chronicle the consequences from the chemical inhibition of two such pathways controlled by the Hedgehog and Wnt signaling molecules in vertebrate embryogenesis and adolescent growth. The findings from this proposal should provide a strategic framework for predicting and countering unwanted effects that are associated with the use of such therapeutic reagents.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HD061303-01
Application #
7691519
Study Section
Special Emphasis Panel (ZRG1-CB-L (50))
Program Officer
Javois, Lorette Claire
Project Start
2009-09-10
Project End
2011-08-31
Budget Start
2009-09-10
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$235,500
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Wang, Xiaolei; Moon, Jesung; Dodge, Michael E et al. (2013) The development of highly potent inhibitors for porcupine. J Med Chem 56:2700-4
Lum, Lawrence; Clevers, Hans (2012) Cell biology. The unusual case of Porcupine. Science 337:922-3
Dodge, Michael E; Moon, Jesung; Tuladhar, Rubina et al. (2012) Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine. J Biol Chem 287:23246-54